US: FTC needs big improvement to define ‘unfair’ competition methods, says Commissioner Wright
The US Federal Trade Commission’s efforts to define “unfair methods of competition,” as stated in Section 5 of the FTC Act, have been mediocre thus far, according to FTC Commissioner Wright. Wright delivered a speech on Section 5 to the New York Bar Association’s Antitrust Section to discuss the clause, which bestows the task of what constitutes “unfair” business practices. But almost a century after the FTC was founded, the regulator’s efforts to fulfill that task have been “uninspiring if not bleak,” according to Wright. The Commissioner has prioritized the task, however, offering a Policy Statement to clearly define unfair methods of competition based on “modern economics and antitrust jurisprudence.” While the proposal is described as a mere “starting point” to the discussion on Section 5, Wright’s proposal offers an outline to define “unfair” as a business practice that “harms or is likely to harm competition significantly” as well as one that “lacks cognizable efficiencies,” according to the Policy Statement. Going forward, said the Commissioner, the FTC must now focus on clarifying what differentiates acceptable and unfair business practices.
Click here to access Commissioner Wright’s full Policy Statement.
Click here to read Commissioner Wright’s full speech.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas